Publication:
Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B

Simple item page
dc.contributor.authorKarsen, H.
dc.contributor.authorBinici, I
dc.contributor.authorSünnetçioğlu, Mahmut
dc.contributor.authorBaran, Ali İrfan
dc.contributor.authorCeylan, Melike
dc.contributor.authorSelek, ŞAHBETTİN
dc.contributor.authorCelik, H.
dc.contributor.institutionauthorSELEK, ŞAHABETTİN
dc.date.accessioned2020-10-29T19:29:55Z
dc.date.available2020-10-29T19:29:55Z
dc.date.issued2012-01-01T00:00:00Z
dc.description.abstractBackground: The hepatitis B virus is a significant pathogen that causes cirrhosis, and hepatocellular cancer as a result of the damage it causes to liver cells. Its infection affects more than 400 million people globally. Although there is an effective vaccine and treatment methods, almost 1, 000, 000 people die every year.
dc.identifier.citationKarsen H., Binici I., Sünnetçioğlu M., Baran A. İ. , Ceylan M., Selek Ş., Celik H., -Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B-, AFRICAN HEALTH SCIENCES, cilt.12, ss.114-118, 2012
dc.identifier.doi10.4314/ahs.v12i2.6
dc.identifier.scopus84864374667
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25829
dc.identifier.wosWOS:000315184900006
dc.titleAssociation of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B
dc.typeArticle
dspace.entity.typePublication
local.avesis.id4f0c7293-6b4c-47e8-8bd1-cd6c1beb4230
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication8eb7d539-8ea4-435c-830e-8ef630342c7d
relation.isAuthorOfPublication.latestForDiscovery8eb7d539-8ea4-435c-830e-8ef630342c7d
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Silinecekler